Evidence mapPaperPMID 33440795Full record

ReviewMolecules (Basel, Switzerland)2021

Melatonin in Wine and Beer: Beneficial Effects.

Javier Marhuenda, Débora Villaño, Raúl Arcusa, Pilar Zafrilla

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Javier MarhuendaFaculty of Health Sciences, Department of Pharmacy, Catholic University of San Antonio (UCAM), Campus de los Jerónimos, Guadalupe, 30107 Murcia, Spain.
Débora VillañoFaculty of Health Sciences, Department of Pharmacy, Catholic University of San Antonio (UCAM), Campus de los Jerónimos, Guadalupe, 30107 Murcia, Spain.
Raúl ArcusaFaculty of Health Sciences, Department of Pharmacy, Catholic University of San Antonio (UCAM), Campus de los Jerónimos, Guadalupe, 30107 Murcia, Spain.
Pilar ZafrillaFaculty of Health Sciences, Department of Pharmacy, Catholic University of San Antonio (UCAM), Campus de los Jerónimos, Guadalupe, 30107 Murcia, Spain.ORCID 0000-0002-1463-7120
Universidad Católica de Murcia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melatonin is a hormone secreted in the pineal gland with several functions, especially regulation of circadian sleep cycle and the biological processes related to it. This review evaluates the bioavailability of melatonin and resulting metabolites, the presence of melatonin in wine and beer and factors that influence it, and finally the different benefits related to treatment with melatonin. When administered orally, melatonin is mainly absorbed in the rectum and the ileum; it has a half-life of about 0.45-1 h and is extensively inactivated in the liver by phase 2 enzymes. Melatonin (MEL) concentration varies from picograms to ng/mL in fermented beverages such as wine and beer, depending on the fermentation process. These low quantities, within a dietary intake, are enough to reach significant plasma concentrations of melatonin, and are thus able to exert beneficial effects. Melatonin has demonstrated antioxidant, anticarcinogenic, immunomodulatory and neuroprotective actions. These benefits are related to its free radical scavenging properties as well and the direct interaction with melatonin receptors, which are involved in complex intracellular signaling pathways, including inhibition of angiogenesis and cell proliferation, among others. In the present review, the current evidence on the effects of melatonin on different pathophysiological conditions is also discussed.

Indexed as

AnimalsAnticarcinogenic AgentsAntioxidantsBeerCircadian RhythmFermentationHumansMelatoninNeuroprotective AgentsWineAnticarcinogenic AgentsAntioxidantsMelatoninNeuroprotective Agentsbeerfree radicalmelatoninpolyphenolswine

Identifiers

PMID33440795
PMCPMC7827953
OpenAlexW3119704278

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.